Evolus (EOLS) Receivables - Other (2017 - 2018)

Evolus' (EOLS) quarterly Receivables - Other came in at $100000.0 in Q1 2018, down 99.86% on a QoQ basis from $72.6 million in Q4 2017.

Evolus (EOLS) Receivables - Other (2017 - 2018) Analysis & Trends

Evolus (EOLS) has 2 years of Receivables - Other data on file, last reported at $100000.0 in Q1 2018.

Quarterly Receivables - Other changed N/A year-over-year to $100000.0 in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $100000.0 (changed N/A YoY) and the FY2017 annual result came in at $72.6 million, changed N/A from the prior year.
Receivables - Other slipped to $100000.0 in Q1 2018, from $72.6 million in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $72.6 million in Q4 2017 to a low of $100000.0 in Q1 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-
10	Evolus	552.49 Mn	507.32 Mn	57.18 Mn

Download Data